ScienceDex / Researcher record
Kirkpatrick, Lynn
- Ensysce Biosciences, Inc. (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Top 5% Funded
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2006 | $1,787,809 | 2 | #2,410 |
| 2007 | $1,831,295 | 2 | #3,064 |
| 2012 | $298,072 | 1 | #26,836 |
| 2013 | $287,434 | 1 | #26,446 |
| 2014 | $225,000 | 1 | #30,022 |
| 2018 | $2,123,989 | 1 | #2,598 |
| 2019 | $8,468,222 | 3 | #261 |
| 2021 | $2,791,255 | 1 | #1,947 |
| 2022 | $2,794,315 | 1 | #1,987 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20062 records
- FY20072 records
- FY20121 record
- FY20131 record
- FY20141 record
- FY20181 record
- FY2019 · selected3 records
- FY20211 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Kirkpatrick, Lynn as a PI. Multi-PI records show the full award amount for context.
- 1UG3DA050271-01UG3Contact PIR-methadone-TAAP/MPAR: an abuse deterrent methadone prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial$5.4Maward amount
- 5UG3DA047682-02UG3Contact PIPF614 MPAR Abuse Deterrent opioid prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial$2.9Maward amount
- 3UG3DA047682-02S1UG3Contact PIPF614 MPAR Abuse Deterrent opioid prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial$129.8Kaward amount
Award organization
Organizations that administered FY2019 awards listing Kirkpatrick, Lynn as a PI.
FY2019 award administered by Ensysce Biosciences, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardEnsysce Biosciences, Inc.
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #2410
- 2006Entered Top 25% NationallyRanked #2410
- 2007$2M Cumulative Funding
- 2018$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2019Entered Top 10% NationallyRanked #261
- 2019Entered Top 5% NationallyRanked #261